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This study aimed to evaluate the survival rate of microorganisms within different antiseptic formulations –
povidone-iodine (PVP-I) and chlorhexidine (CHX) – after intentional contamination, and to establish the minimum
care necessary to ensure sterilization of non-disposable antiseptic solution containers. A laboratory study was
performed with 180 antiseptic containers, which were contaminated with Serratia marcescens [1 x 105 UFC/
mL]. The containers were closed and stored, at room temperature, during seven days and shaken daily. The
antiseptic cultures were evaluated to be 100% negative to Serratia marcescens in all of the non-disposable
containers. These results suggested that antiseptic solutions inactivate microorganisms [1 x 105 UFC/mL].
Since cleaned antiseptic containers have around 102 UFC coming from tap water, it can be inferred that
cleansing is a safe minimum procedure to ensure reuse of containers for distribution of CHX and PVP-I solutions
in aqueous, detergent and alcoholic formulations.
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EVALUACIÓN MICROBIOLÓGICA DE LAS DIFERENTES FORMULACIONES ANTISÉPTICAS,
POLIVINIL-PIRROLIDONA-YODO Y CLOREXIDINA, DESPUÉS DE LA CONTAMINACIÓN
INTENCIONAL DE LOS RECIPIENTES
Los objetivos de este estudio fueron evaluar la sobre vivencia de los micro organismos en las diferentes
formulaciones de los antisépticos clorexidina (CHX) y polivinil-pirrolidona–yodo (PVP-Y), después de una
contaminación intencional de los recipientes y extrapolar los resultados de los laboratorios para el cuidado
mínimo a ser dispensado a los recipientes de múltiple uso para el envase de los antisépticos probados. Para
esto, fue desarrollado un estudio de laboratorio, en que 180 recipientes fueron contaminados con 1 x 105 UFC/
mL de suspensión conteniendo S.marcescens. Después de la contaminación, seis diferentes formulaciones de
antisépticos (clorexidina y PVP-Y en los vehículos alcohólico, detergente y acuoso) fueron distribuidos y sometidos
a la cultura diaria durante siete días, a fin de verificar se hubo crecimiento del microorganismo. Los resultados
de esta investigación permiten recomendar la limpieza como el procedimiento mínimo en el procesamiento de
esos recipientes que garantiza la seguridad de su utilización repetida para distribución de los antisépticos que
fueron sometidos a prueba – CHX y PVP-Y.
DESCRIPTORES: agentes antiinfecciosos locales; contaminación; infección hospitalar
AVALIAÇÃO MICROBIOLÓGICA DAS DIFERENTES FORMULAÇÕES ANTI-SÉPTICAS,
POLIVINILPIRROLIDONA-IODO E CLOREXIDINA, APÓS CONTAMINAÇÃO INTENCIONAL
DAS ALMOTOLIAS
Os objetivos deste estudo foram: avaliação da sobrevivência dos microrganismos nas diferentes formulações
dos anti-sépticos clorexidina (CHX) e polivinilpirrolidona–iodo (PVP-I), após contaminação intencional das
almotolias, e extrapolar os resultados laboratoriais para o cuidado mínimo a ser dispensado às almotolias de
múltiplo uso para o envase dos anti-sépticos testados. Para tanto, foi desenvolvido estudo laboratorial, em que
180 almotolias foram contaminadas com 1 x 105 UFC/mL de suspensão, contendo S.marcescens. Após a
contaminação, seis diferentes formulações de anti-sépticos (clorexidina e PVP-I nos veículos alcoólico, degermante
e aquoso) foram distribuídas e submetidas à cultura diária durante sete dias, a fim de verificar se houve
crescimento do microrganismo. Os resultados desta investigação permitem a recomendação de que a limpeza
como procedimento mínimo no processamento desses recipientes garante a segurança de sua utilização repetida
para distribuição dos anti-sépticos testados – CHX e PVP-I.
DESCRITORES: antiinfecciosos locais; contaminação; infecção hospitalar
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INTRODUCTION
Antiseptics are anti-microbial substances
used on skin and mucosa to reduce bacterial counts(1).
Attempts to use these agents to prevent infections
and reduce their complications originated in
Hippocrates’ time. Currently, the main use of
antiseptics in health institutions is: to cleanse hands,
to prepare patients’ skin before surgery, to degerm
hands and forearms of the surgical team, and in some
invasive procedures like central and arterial venous
puncture, vascular and vesical catheterism, among
others, where the individual’s normal barriers of
defense are broken(1-2).
Reports found in the literature regarding
antiseptic products infected by microbiological
contamination are a cause of concern for professionals
in the area of infection control related to health care,
because these contaminations have been the cause
of outbreaks in hospitals(1-2).
Despite uncertainties regarding
microbiological resistance to biocides, concentrations
currently used in health services are considerably
higher that the Minimum Inhibitory Concentration
(MIC) of bacteria able to grow in antiseptic solutions(10).
The contamination of these solutions is mainly
associated to exogenous causes. Inadequate storage
and failure in keeping the stability of the product
formulation can partially contribute to the apparent
contamination found in practice(11).
Contamination related to the processing of
containers, whose practice is largely discussed in
health services with no scientific basis, was not found
among publications on antiseptic contamination.
Therefore, this study aimed to evaluate the survival
rate of microorganisms within different formulations
of antiseptics – CHX and PVPI-I – after intentional
contamination of containers with Serratia marcescens
and, based on laboratory results, to establish minimum
care to be delivered to non-disposable containers used
to store antiseptics.
MATERIAL AND METHOD
Experimental, laboratory study, developed in
the Laboratory of Microbiology at the Department of
medical-surgery nursing at the University of Sao Paulo,
School of Nursing.
Inoculum A sample of the culture Serratia
marcescens ATCC 14756 was kept in BHI (Brain Heart
Infusion) culture and undercultivated in Tryptone Soy
Broth (TSB). After 105 UFC/ml of inoculum size was
confirmed (turbidity equivalent in the McFarland scale),
the material was used to contaminate the containers.
The inoculation of containers was done in 1 mL collected
through automated mini-pipette and distributed on the
entire internal container wall with rotating movements.
Sample size: after the pretest, the experiment
sample size was established at 30 samples for each
formulation (CHX and PVP-I in aqueous, detergent
and alcoholic formulations), totaling 180 containers,
with 95% confidence interval (p<0.05).
Experimental planning: The investigated
antiseptic solutions - CHX and PVP-I – in the aqueous,
detergent and alcoholic formulations were divided in
two groups and tested at different moments: Group I
– chlorhexidine and Group II - PVP-I. First, 90
containers were intentionally contaminated with 1mL
of 105 UFC/mL of S. marcescens suspension. The three
different formulations of chlorhexidine antiseptic
(alcoholic, detergent and aqueous) were distributed
in 150ml volumes. To make sure the experiments
were initiated with no microorganisms, all containers
were previously cleaned and sterilized with ethylene
oxide (ETO).
The containers were lidded and stored at
room temperature for seven days and shaken daily,
three times a day, at 8AM, 2PM and 8PM, so that the
antiseptic solutions would enter in contact with surfaces
above the 150mL level.
Aliquot parts of 1mL of each of the 90 solutions
of CHX in test were pipetted daily and transferred to
tubes containing the culture, in order to verify the
growth of S. marcescens. Therefore, at the end of
seven days, 630 TSB solutions were cultivated (90
per day during seven days) and inoculated with the
antiseptic sample contaminated with the test
microorganism. The inoculated tubes were incubated
at room temperature during 21 days, with daily
reading in the first week, and on the 7th, 14th and 21st
days.
After one month, the study continued with
group II, using the same work method, in which the
PVP-I solutions were tested in the three different
formulations (alcoholic, detergent and aqueous).
The media were prepared by adding a specific
neutralizer for chlorhexidine (tween 80 0.5%) and for
the PVP-I (sodium sulphite 0.1%).
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Positive control: growth of test microorganism
in 10 mL of TSB to control the strain viability and
equivalence to the prepared media (two tubes).
Negative control: two limpid TSB (two tubes)
incubated at 22ºC for 72 hours indicated absence of
microorganisms.
RESULTS
In the experiments of groups I and II, 100%
of the culture media were kept limpid, evidencing
absence of test microorganisms. The negative controls
were kept limpid after 21 days of reading. The positive
controls became turbid in 24 hours, while a red
coloration, characteristic of S. Marcescens, was
observed in 48 hours. Data on microorganism growth
in groups I and II are summarized in table 1.
stluseR -IpuorG XHC
-IIpuorG
I-PVP
evitisoP
lortnoC
evitageN
lortnoC
htworGevitisoP 036/0 036/0 2/2 2/0
htworGevitageN 036/036 036/036 2/0 2/2
Table 1 – Distribution of results of microbiological
cultures of antiseptic tested in Groups I and II after
21 days of incubation. São Paulo, 2007
DISCUSSION
The processing of non-disposable containers
is a practice not explained in the literature and largely
discussed in health services with no scientific basis.
The method used to search for the minimum procedure
indicated for the processing of these containers was
to verify the antiseptics’ capacity to inactivate
microorganisms intentionally inoculated in the
containers through contamination in the order of 1 x
105 UFC/mL. This inoculum was considered strong
due to the potential contamination antiseptics would
be exposed to when bottled in containers cleaned only
with tap water and detergent.
When the results of this study are
extrapolated, cleansing is verified to be the minimum
procedure required before safe reuse of containers,
because the load of microorganisms present in the
cleaned container would certainly be smaller that the
inoculum challenge of 1 x 105 UFC/mL. Therefore, a
new challenge emerges in the processing of these
containers: the heterogeneous contamination of the
rinse water. Researchers have showed there is low
microbiological load in surgical material after cleaning,
on the average 102 UFC/ material(12-14).
The legal parameters for water potability, Rule
nº 518 of March 25th, 2004, issued by the Brazilian
Ministry of Health, “establishes the procedures and
responsibilities related to the control and surveillance
of water quality for human consumption and its
potability standards, in addition to other necessary
steps”(15). The expected microbiological standard is
found with a tolerance of contamination much lower
than the tested inoculum in this study: absence of E.
coli or thermotolerant coliforms in 100mL of water.
This is an original in vitro study, since
publications that presented contamination of
antiseptics result from outbreaks in care practice. In
Brazil, laboratory studies on microbiological action of
biocides gained expression as from the 1980s(16).
The main references consulted on antiseptic
contamination appoint issues of handling and
inadequate care that lead to product instability and
allow microorganisms to grow(3-6).
Cases of antiseptic contamination were also
reported with findings of organic debris in the solution
and biofilm on internal container walls, evidenced by
electronic microscopy(7-9). Their presence might have
provided protection to the contaminant. The formation
of biofilm is a process in which microorganisms
irreversibly adhere and grow on the surface, producing
extracellular polymer that ease adherence and matrix
formation. However, physical methods, such as
mechanical cleansing or friction, or even ultrasound,
are effective in assuring its removal, provided that it
is adequately performed(17).
As previously mentioned, concentrations
currently used in health services are substantially
higher than the Minimum Inhibitor Concentration of
these bacteria(10). Thus, the contamination of antiseptic
solutions is not currently associated to reduced
susceptibility of microorganisms.
Deductive reasoning was used in this study
to conclude that cleaning is the minimum procedure
for processing containers in which antiseptics are
bottled. This consideration is strongly based on studies
that confirm that the number of microorganisms
recovered from only cleaned material is around 102
UFC(12-14). Considering this deductive reasoning,
adequate care with cleaning, rinsing, and drying
containers is important for safety control. Residues
of detergent can occasionally destabilize chemical
formulations, and residues from rinse water can dilute
antiseptic concentration.
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Further studies can confirm this deductive
reasoning, analyzing residual microorganisms
(quantitatively and qualitatively) in containers cleaned
only with tap water and detergent in different hospital
institutions.
Finally, results of this study provide answers
for container processing practice, which was not
scientifically based yet. It can be affirmed that the
repetitive use of these containers after the cleaning
process is a safe practice, making the process easy
and economical for the centers of material sterilization
in health institutions. Another aspect worth mentioning
is the ecological issue involved, with reduced
generation of residues from disposable products in
the health services.
CONCLUSION
This study allowed for the following
conclusions:
Tested antiseptic (chlorhexidine and PVP-I in
aqueous, detergent and alcoholic solutions) inactivated
microorganisms intentionally inoculated in containers
in a concentration of 1 x 105 UFC/mL.
Considering that cleaned containers carry
vegetative microorganisms from the rinse water in
the order of 102 UFC, it can be inferred that cleaning
is considered safe as a minimum procedure for
repetitive use of these containers in the distribution
of the tested antiseptics – chlorhexidine and PVP-I, in
detergent, aqueous and alcoholic formulations.
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